A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status:
Completed
Trial end date:
2019-07-05
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the pharmacokinetics (PK), safety and tolerability of
multiple doses of intravenous (IV) and oral isavuconazonium sulfate administered daily in
pediatric patients. The PK data will be utilized to establish a pediatric population PK model
of isavuconazole, the active moiety of isavuconazonium sulfate.